251 related articles for article (PubMed ID: 36824351)
1. Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation.
Almeida C; Pedro AQ; Tavares APM; Neves MC; Freire MG
Front Bioeng Biotechnol; 2023; 11():1037436. PubMed ID: 36824351
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation.
Almeida C; Pedro AQ; Tavares APM; Neves MC; Freire MG
Front Bioeng Biotechnol; 2023; 11():1213921. PubMed ID: 37229491
[TBL] [Abstract][Full Text] [Related]
3. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
[TBL] [Abstract][Full Text] [Related]
4. From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies.
Elsayed A; Jaber N; Al-Remawi M; Abu-Salah K
Int J Pharm; 2023 Oct; 645():123360. PubMed ID: 37657507
[TBL] [Abstract][Full Text] [Related]
5. Continuous Chromatography Purification of Virus-Based Biopharmaceuticals: A Shortcut Design Method.
Silva RJS; Mendes JP; Carrondo MJT; Marques PM; Peixoto C
Methods Mol Biol; 2020; 2095():367-384. PubMed ID: 31858479
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals.
Emami F; Keihan Shokooh M; Mostafavi Yazdi SJ
J Pharm Investig; 2023; 53(1):35-57. PubMed ID: 36568503
[TBL] [Abstract][Full Text] [Related]
7. Ionic liquids as biocompatible stabilizers of proteins.
Reslan M; Kayser V
Biophys Rev; 2018 Jun; 10(3):781-793. PubMed ID: 29511969
[TBL] [Abstract][Full Text] [Related]
8. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
[TBL] [Abstract][Full Text] [Related]
9. Efficient Isolation of Bacterial RNAs Using Silica-Based Materials Modified with Ionic Liquids.
Pereira P; Pedro AQ; Neves MC; Martins JC; Rodrigues I; Freire MG; Sousa F
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685465
[TBL] [Abstract][Full Text] [Related]
10. Innovative Drying Technologies for Biopharmaceuticals.
Sharma A; Khamar D; Cullen S; Hayden A; Hughes H
Int J Pharm; 2021 Nov; 609():121115. PubMed ID: 34547393
[TBL] [Abstract][Full Text] [Related]
11. Separation science is the key to successful biopharmaceuticals.
Guiochon G; Beaver LA
J Chromatogr A; 2011 Dec; 1218(49):8836-58. PubMed ID: 21982447
[TBL] [Abstract][Full Text] [Related]
12. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals.
Puranik A; Dandekar P; Jain R
Biotechnol Prog; 2022 Nov; 38(6):e3291. PubMed ID: 35918873
[TBL] [Abstract][Full Text] [Related]
13. Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals.
Zeb A; Rana I; Choi HI; Lee CH; Baek SW; Lim CW; Khan N; Arif ST; Sahar NU; Alvi AM; Shah FA; Din FU; Bae ON; Park JS; Kim JK
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291312
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation.
Castro LS; Lobo GS; Pereira P; Freire MG; Neves MC; Pedro AQ
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915863
[TBL] [Abstract][Full Text] [Related]
15. Ionic liquids as protein stabilizers for biological and biomedical applications: A review.
Veríssimo NV; Vicente FA; de Oliveira RC; Likozar B; Oliveira RPS; Pereira JFB
Biotechnol Adv; 2022 Dec; 61():108055. PubMed ID: 36374851
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceuticals from microorganisms: from production to purification.
Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
[TBL] [Abstract][Full Text] [Related]
17. Formulations strategies for biopharmaceuticals--ensuring success to market.
Atkinson EM; Klum W
IDrugs; 2001 May; 4(5):557-60. PubMed ID: 16012901
[TBL] [Abstract][Full Text] [Related]
18. Secondary Packages cannot Protect Liquid Biopharmaceutical Formulations from Dropping-Induced Degradation.
Fang WJ; Liu JW; Gao H; Qian YC; Gao JQ; Wang H
Pharm Res; 2021 Aug; 38(8):1397-1404. PubMed ID: 34282500
[TBL] [Abstract][Full Text] [Related]
19. Supported Ionic Liquids Used as Chromatographic Matrices in Bioseparation-An Overview.
Bernardo SC; Carapito R; Neves MC; Freire MG; Sousa F
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268719
[TBL] [Abstract][Full Text] [Related]
20. Insights on the Formulation of Recombinant Proteins.
Ribeiro R; Abreu TR; Silva AC; Gonçalves J; Moreira JN
Adv Biochem Eng Biotechnol; 2020; 171():23-54. PubMed ID: 31844925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
